Acquisition increases capacity to deliver high quality, locally manufactured oligos
Skokie, IL – December 1, 2015. Integrated DNA Technologies Inc. (“IDT”), the global leader in custom nucleic acid synthesis, has entered into a definitive agreement to acquire the oligonucleotide synthesis business of AITbiotech Pte. Ltd. in Singapore (“AITbiotech”). With this acquisition, IDT expands its customer base across Southeast Asia making it possible for these additional customers to now have access to its broad range of products for genomic applications. AITbiotech will continue operations in its other core business areas.
Dr. Joseph A. Walder, IDT founder and chief executive officer, commented, “With this purchase, we further expand our presence in the region and look forward to welcoming AITbiotech customers to IDT. The entire Singapore scientific research market can now benefit from IDT’s unrivalled manufacturing capabilities, design expertise and fast turnaround times.”
Alex Thian, chief executive officer of AITbiotech, added, “We share a commitment with IDT to produce consistently high-quality oligos and to provide personal service for customers. Both companies are working diligently to facilitate a smooth transition of the business and we are excited to begin this next chapter in the ever expanding Singapore market.”
Follow us on twitter @idtdna for real-time updates and insights.
Integrated DNA Technologies, Inc. (IDT), the global leader in nucleic acid synthesis, serving all areas of life sciences research and development, offers products for a broad range of genomics applications. IDT’s primary business is the production of custom, synthetic nucleic acids for molecular biology applications, including qPCR, sequencing, synthetic biology, and functional genomics. The company manufactures and ships an average of 44,000 custom nucleic acids per day to more than 82,000 customers worldwide. For more information, visit www.idtdna.com.
Integrated DNA Technologies
800-328-2661 (US & Canada)
+1 319-626-8400 (outside US)
Founded by Alex Thian in 2008, AITbiotech is a leading MDx company and provides a complete suite of genomics services to research, healthcare, and biomedical industries in Singapore and Asia. The company’s MDx business focuses on infectious diseases, oncology genetic testing and pharmacogenetics. AITbiotech is ISO 13485 certified and has its facility located at Science Park I Singapore. For more information, please visit our website: www.aitbiotech.com.
Ms. Tan Shirley
Senior Business Director
AITbiotech Pte Ltd
+65 6778 6822